Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25310046 | 0.91 | TSHR (0.56) | TSHRNAAAIDO1LTA4HAGXT | |
| SCHEMBL19520 | 0.88 | TSHR (0.70) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL1991359 | 0.88 | TSHR (0.78) | TSHRNAAAIDO1LTA4HAGXT | |
| SCHEMBL30397113 | 0.86 | TSHR (0.67) | TSHRNAAAIDO1AGXTALDH1A1 | |
| SCHEMBL10660158 | 0.86 | TSHR (0.67) | TSHRNAAAIDO1AGXTALDH1A1 | |
| Phosphine SCHEMBL7705717 | 0.86 | TSHR (0.67) | TSHRNAAAIDO1AGXTALDH1A1 | |
| SCHEMBL4608747 | 0.85 | TSHR (0.74) | TSHRNAAAIDO1LTA4HAGXT | |
| SCHEMBL9505432 | 0.85 | TSHR (0.74) | TSHRNAAAIDO1LTA4HAGXT | |
| SCHEMBL10895400 | 0.85 | TSHR (0.74) | TSHRNAAAIDO1LTA4HAGXT | |
| SCHEMBL26189828 | 0.85 | TSHR (0.74) | TSHRNAAAIDO1LTA4HAGXT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119110793-A | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | 株式会社力森诺科 | 2024-12-10 | — | — | CN | disclosed |
| US-RE46234-E1 | Tissue adhesive and sealant comprising polyglycerol aldehyde | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2016-12-13 | — | — | US | disclosed |
| EP-2411062-B1 | TISSUE ADHESIVE AND SEALANT COMPRISING POLYGLYCEROL ALDEHYDE | ACTAMAX SURGICAL MATERIALS LLC (US) | 2014-08-20 | — | — | EP | disclosed |
| US-8680200-B2 | Polyglycerol aldehydes | ACTAMAX SURGICAL MATERIALS LLC (US) | 2014-03-25 | — | — | US | disclosed |
| US-8404779-B2 | Tissue adhesive and sealant comprising polyglycerol aldehyde | ACTAMAX SURGICAL MATERIALS LLC (US) | 2013-03-26 | — | — | US | disclosed |
| EP-2411448-B1 | POLYGLYCEROL ALDEHYDES | ACTAMAX SURGICAL MATERIALS LLC (US) | 2013-03-20 | — | — | EP | disclosed |
| US-8334320-B2 | Methods for chelation therapy | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-12-18 | — | — | US | disclosed |
| US-20120029149-A1 | POLYGLYCEROL ALDEHYDES | ACTAMAX SURGICAL MATERIALS, LLC (US) | 2012-02-02 | — | — | US | disclosed |
| EP-2411448-A1 | POLYGLYCEROL ALDEHYDES | Actamax Surgical Materials LLC (US) | 2012-02-01 | — | — | EP | disclosed |
| EP-2411062-A1 | TISSUE ADHESIVE AND SEALANT COMPRISING POLYGLYCEROL ALDEHYDE | Actamax Surgical Materials LLC (US) | 2012-02-01 | — | — | EP | disclosed |
| EP-0452680-A1 | Substituted purines, process for their preparation and their use as antiviral agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-10-23 | — | — | EP | disclosed |
| EP-0193347-B1 | 13-SUBSTITUTED DERIVATIVES OF AVERMECTIN AGLYCONES | MERCK & CO. INC. (US) | 1990-08-29 | — | — | EP | disclosed |
| EP-0201166-B1 | ERYTHROMYCIN DERIVATIVES | BEECHAM GROUP PLC (GB) | 1990-02-07 | — | — | EP | disclosed |
| US-4847242-A | ANTIBIOTICS | BEECHAM GROUP P.L.C. (GB) | 1989-07-11 | — | — | US | disclosed |
| US-4801710-A | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives | MERCK & CO., INC. (US) | 1989-01-31 | — | — | US | disclosed |
| EP-0193347-A2 | 13-Substituted derivatives of avermectin aglycones | MERCK & CO. INC. (US) | 1986-09-03 | — | — | EP | disclosed |
| EP-0184473-A1 | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives | MERCK & CO. INC. (US) | 1986-06-11 | — | — | EP | disclosed |
| US-4587247-A | ANTHELMINTIC, PARASITICIDES | MERCK & CO., INC. (US) | 1986-05-06 | — | — | US | disclosed |
| EP-0158513-A2 | Antiviral compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1985-10-16 | — | — | EP | disclosed |
| US-4225706-A | Polychalcogen ester of cephem compound, process for preparing the same and method for removing the protective group of the same | MEIJI SEIKA KAISHA LTD. (JP) | 1980-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029149-A1 | POLYGLYCEROL ALDEHYDES | GGH, TGM3, FABP2 | TSHR 4315/4885NAAA 491/4885IDO1 1979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.